Akzo Nobel N.V. (AMS:AKZA)
Netherlands flag Netherlands · Delayed Price · Currency is EUR
57.54
+0.24 (0.42%)
Sep 16, 2026, 5:38 PM CET
← View all transcripts

Earnings Call: Q4 2017

Mar 8, 2018

Operator

Welcome, and thank you for standing by. At this time, all participants will be on listen-only mode until the question and answer session of today's conference. At that time, to ask a question, please press star followed by the number 1 on your phone and record your name at the prompt. Today's conference is being recorded. If you have any objections, you may disconnect at this time. May I now introduce your speaker for today, Lloyd Midwinter. Please go ahead.

Lloyd Midwinter
Director of Investor Relations, Akzo Nobel

Hello, and welcome to the Akzo Nobel investor update for full year in Q4 2017. I am Lloyd Midwinter, Director of Investor Relations. Today, our CEO, Thierry Vanlancker, and CFO, Maarten de Vries, will guide you through our results. We will refer to a presentation which you can follow on-screen and download from our website, akzonobel.com. A replay of this call will also be made available. There will be an opportunity to ask questions after the presentation. For additional information, please contact Investor Relations. Before we start, I would like to remind you about the disclaimer at the back of the presentation. Please note this is also applicable to the conference call and answers to your questions. I now hand over to Thierry, who will start on slide three of the presentation.

Thierry Vanlancker
CEO, Akzo Nobel

Thank you, Lloyd, good morning to everyone, and thank you for joining us on this call. 2017 for Akzo Nobel was in many aspects an extraordinary year. Before we dive into all those elements and numbers, I want to compliment my team for making significant progress since we announced our strategy to create two focused high-performance businesses, Paints and Coatings on the one hand, and Specialty Chemicals on the other. The separation of Specialty Chemicals is fully on track for April 2018, as announced and as planned, and the business is now reported as discontinued operations. I thought it was relevant to keep that in mind as we discuss the financial results later in the presentation. I would, however, like to highlight some of our achievements for this combined Paints and Coatings and Chemicals, the traditional Akzo Nobel, if I may say.

We delivered another year of record EBIT and real organic growth, driven by higher volumes for both Paints and Coatings and Specialty Chemicals, supplemented with three bolt-on acquisitions. The phase 1 of creating a fit-for-purpose Paints and Coatings organization, announced in October 2017, is on track to achieve the EUR 110 million savings in 2018. Throughout 2017, we continued to act in line with our core principles. We achieved top-quartile safety performance, which is now truly world-class, and we were ranked number 1 again on the Dow Jones Sustainability Index for the chemical industry. We also kept engaged on some of our social programs, like Let's Colour Walls of Connection in many cities around the world. On slide four, we see some key financial highlights.

For the full year, the revenue was up 4%, excluding currency. The EBIT was 2% higher than a record in 2016, and therefore, a new record. The adjusted earnings per share was up 6% at EUR 4.4, and the total dividend proposed for 2017 is up 52% to become EUR 2.5 per share. During the fourth quarter, we made further progress. The revenue was up 6%, excluding currency, and EBIT was 30% higher than last year. Adjusted earnings per share was up 39% at EUR 4.92. We continue delivering growth and increased profits. Let's turn to slide number five. During 2017, positive developments continued for Decorative Paints, particularly in our Asia business, while challenging conditions in the marine and oil and gas industries impacted Performance Coatings. We continued also to see higher demand for Specialty Chemicals in all our regions.

Some headwinds persisted, including higher raw material costs and adverse effects from foreign currencies increasing throughout the year. We're capitalizing on positive market trends and dealing with specific headwinds. We also continue to invest in our sites as well as on bolt-on acquisitions to support our organic growth. Some recent examples are shown here on slide number six. During 2017, Specialty Chemicals announced or completed a further 14 capacity expansions to support customer growth in all regions. On the Paints and Coatings side, we officially opened our new Ashington site in the U.K., which is the world's most advanced and sustainable paint plant and a new center of production for Dulux in the U.K. Having acquired BASF's Industrial Coatings business at the end of 2016, we made three further bolt-on acquisitions during 2017, including Disatec in France, Flexcrete in the U.K., and V.Powdertech in Thailand.

Turning to slide number seven. The separation of Specialty Chemicals, either via a private sale or a legal demerger, remains fully on track for April 2018. The internal separation of the Specialty Chemicals business is now complete. We are pursuing a dual-track process to achieve a full separation, and will return the vast majority of the proceeds to shareholders as indicated in April 2017. I will now hand over to Maarten, who will take you through the financials in more detail from slide nine onwards. Maarten.

Maarten de Vries
CFO, Akzo Nobel

Thank you, Thierry. Hello to everybody on the call. I, of course, look forward to meeting you all. As Thierry mentioned, Specialty Chemicals is now reported as discontinued operations, so please keep this in mind as I run you through the financial results. For the full year, Paints and Coatings revenue was up 4%, excluding currencies, driven by higher volumes and acquisitions. Price mix was impacted by strong growth in emerging markets. EBIT was 2% lower due to higher raw material costs, partly offset by increased selling prices, continuous improvements, and cost control. Internal sales was 9.4% versus 9.8% in 2016. The operating income includes identified items of EUR 80 million, mainly related to the transformation of the Paints and Coatings organization. Turning to slide 10. During the fourth quarter, Paints and Coatings revenue was up 5%, excluding currencies, driven by higher volumes for Decorative Paints.

Price mix continued to be impacted by strong growth in emerging markets. EBIT was up 19%, with increased selling prices, continuous improvement in cost control, partly offset by higher raw material costs. Internal sales increased to 7.8% compared to 6.5% last year. Turning now to Decorative Paints on slide 11. For the full year, volumes increased with 7%, with growth in all regions. Revenue was up 4%, excluding currencies. Price mix was impacted by strong growth in emerging markets, where average selling prices are lower than slower-growing, more mature markets. Volumes were up for Europe, Middle East, and Africa, with positive developments in most parts of the region, while the U.K. was affected by lower consumer confidence. Adverse currency effects were mostly related to the pound sterling. Revenue for Latin America grew 7% due to higher volumes across the region.

Positive demand trends continued in Asia. Revenue was 8% higher, driven by strong growth, particularly in China, and up 14%, excluding the currency impact. Significant growth was realized in both the premium and mass-market segments. Vietnam and Indonesia also continued to deliver good revenue growth. Overall, EBIT was 2% lower due to adverse currency effects and steep increase in raw material costs, partly offset by continuous improvement in cost control. Internal sales was 9% compared to the 9.3% last year. Slide 12. During the fourth quarter, Decorative Paints revenue was up 7%, excluding currencies. Strong volume growth was partly offset by adverse currency and price mix effects. Positive developments continued, especially in China, and growth improved in Latin America as well as other regions. Revenue for EMEA was up 3%, excluding currencies, mainly due to higher volumes.

Demand trends differed per country in the region, and uncertainty continued in some markets, including the U.K. Latin America grew revenue by 14%, excluding currencies, driven by higher volumes. Revenue for Asia increased with 9%, excluding currencies, with strong volume growth partly offset by adverse price mix due to significant growth in the mass market. EBIT was up with 14%, driven by volume growth, increased selling prices, continuous improvement, and cost discipline, partly offset by adverse currencies and higher raw material costs. Internal sales finally increased to 6.3% versus 5.7% in 2016. Turning over now to Performance Coatings on Slide 13. Full-year revenue for Performance Coatings was up 4%, excluding currencies, mainly due to the acquired Industrial Coatings business. Volume growth in most segments and regions was more than offset by adverse conditions in the marine and oil and gas industries.

Volumes increased for Specialty Coatings in most regions. Revenue was up, mainly due to positive price mix effects. Automotive Coatings revenue grew for all regions. Volumes for Powder Coatings were also higher, while demand for Industrial Coatings differed per region and segment. EBIT was impacted by higher raw material costs and lower volumes, partly compensated by continuous improvement in cost control. Return on sales was 11.6% versus 13.4% last year. For the fourth quarter, and that's slide 14, Performance Coatings revenue was up 3%, excluding currencies. Volumes increased for Industrial and Powder Coatings as well as Automotive and Specialty Coatings. However, adverse conditions persisted in the marine, oil, and gas industries. Volumes in Marine Coatings continued to be affected by the slowdown of new build activity, despite some recovery in all segments. Protective Coatings volumes decreased due to fewer oil and gas projects.

Improvement actions and cost control measures remain a key focus for us in this segment. Revenue for Automotive Coatings and Specialty Coatings was up 6%, excluding currencies, due to higher volumes. Industrial Coatings and Powder Coatings revenue increased by 10%, excluding currencies, due to the acquired Industrial Coatings business, volume growth, and positive price mix. Fourth quarter EBIT was impacted by adverse currencies, higher raw material costs, and lower volumes, partly compensated by continuous improvement in cost control. The overall return on sales was 9.7%, compared to 10.9% in 2016. Turning now to slide 15, which shows the quarterly trends in volume and price mix. Decorative Paints has continued to deliver strong volume growth, while bolt-on acquisitions are contributing to growth for Performance Coatings. Price mix for Decorative Paints continued to be impacted by higher volumes in emerging markets, where average selling prices are lower compared to more mature markets.

Please note that these emerging markets are highly profitable and fast-growing. We have been increasing selling prices during the second half of 2017 and continue to increase selling prices to deal with the higher raw material costs. Although these measures are expected to take several quarters before the necessary mitigating impact is fully realized. Slide 16, you see the main EBIT developments for 2017. Foreign currency turned from being a positive in the first quarter to increasing unfavorable during the year. There was minimal impact from the acquired Industrial Coatings business, as we integrate the operations and production volume is being transferred to nearby Akzo Nobel manufacturing facilities. Higher volumes for Decorative Paints contributed positively, partly offset by lower volumes for Performance Coatings due to ongoing weakness in Marine, oil, and gas.

Price mix was impacted by strong growth for Decorative Paints in emerging markets, where average selling prices are lower than slower-growing, more mature markets. Price mix was flat for Performance Coatings overall. Raw material prices were higher compared with the previous year. This represented a headwind of nearly EUR 300 million during 2017. We continue to implement increased selling prices to deal with the higher raw material costs. Productivity improvements from our ALPS continuous improvement program achieved cost savings at a similar rate to previous years and more than offset wage and other fixed cost inflation. Strict cost control contributed positively to achieving the results. Turning now to Specialty Chemicals on slide 17, which we have reported as discontinued operations. Full-year revenue increased to 5%, excluding currencies, due to positive volume developments and price mix effects. Volumes were up in all business units and regions.

Europe, Asia, Latin America showed particularly strong growth during the whole year, while North America suffered most from supply chain disruptions such as Hurricane Harvey. EBIT was up with 10%, with higher volumes and cost control more than compensating for inflation and raw material price increases. Return on sales increased to 13.8% from 13.2% last year. Turning to slide 18. During the fourth quarter, Specialty Chemicals revenue was up with 9%, excluding currencies, due to positive volume developments and price mix effects. Volumes were up in all regions and business units. In Europe, the business benefited from good demand and strong pricing, while Asia continued a strong year and Latin America ended with a very strong quarter. Positive price mix reflects the successful pass-through of raw material price inflation.

Fourth quarter EBIT was 40% higher, with favorable volumes, price mix developments, and cost control improving the results significantly versus last year. Return on sales increased to 13.4% compared to 10.1% in 2016. Turning to slide 19. Free cash flow for continuing and discontinued operations as shown here, was impacted by changes in working capital, provisions, and identified items. Turning to slide 20. Cash management discipline, in particular, operating working capital and capital expenditure continues to be an area of focus. We perform well compared to peers when it comes to operating working capital, and our disciplined approach to capital expenditure continued in 2017, even while invested in growth. We will maintain this discipline and seek to improve further going forward. Slide 21. During 2017, we paid a special cash dividend related to the separation of Specialty Chemicals.

This impacted our net cash generation and net debt as shown here on this slide. On slide 22, we outline the development of the pension deficit according to IAS 19. The remeasurement effects of liability experience and demographic assumption changes, as well as top-up payments of EUR 275 million in 2017, reduced the deficit. Pension plans of Specialty Chemicals had a deficit of EUR 0.5 billion, according to IAS 19, and are now classified as held for sale. This means that the pension plans related to the continuing operations have a surplus of €0.4 billion according to IAS 19. However, it is important to note these pension plans have an actuarial deficit, and the top-up payments are based on this valuation methodology. Turning to slide 23. Our dividend policy is to pay a stable to rising dividend each year.

The total dividend proposed for 2017 is up with 52% to €2.50 per share, following a similar increase in the interim dividend and in line with our announcements in April last year. The special cash dividend of €4 per share was also paid in December 2017 as advance proceeds related to the separation of Specialty Chemicals. I will now hand back to Thierry for some concluding remarks from slide 25 onwards.

Thierry Vanlancker
CEO, Akzo Nobel

Thank you very much, Maarten. We are clearly on track to create two focused, high-performing businesses, including the separation of Specialty Chemicals by April 2018. Akzo Nobel delivered, in a very eventful year, another year of record EBIT and real organic growth, supplemented, as I stated before, by three bolt-on acquisitions. The phase 1 of creating a fit-for-purpose paints and coatings organization, as announced in October 2017, is on track to achieve €110 million of savings in 2018. Turning to our outlook shown on slide 26. The headwinds that we experienced during 2017, including much higher raw material costs and adverse effects from foreign currencies, are projected to continue in 2018, especially during the start of the year. We anticipate positive ongoing developments for Decorative Paints in all regions, particularly in Asia.

The trends for Performance Coatings are expected to be overall positive for most segments and regions, while still remaining challenging for Marine and Protective Coatings. We continue to implement various measures to mitigate the current market challenges, including increased selling prices and a strict cost discipline. Our Winning together: 15 by 20 strategy will increase and create a focused paints and coatings company to deliver on our 15% return on sales by 2020 guidance. I will now hand it back over to Lloyd for information about upcoming events and the Q&A session. Lloyd?

Lloyd Midwinter
Director of Investor Relations, Akzo Nobel

Thanks, Thierry. Before we start the Q&A session, I would like to draw your attention to some upcoming events shown on slide 27. We will hold an analyst roundtable later today, and the presentation taking place at 1400 CET will be made available by video webcast on our website, akzonobel.com. We will publish our annual report next week on March the 15th and announce our Q1 results for 2018 on April the 24th, shortly followed by our AGM on April the 26th. This concludes our formal presentation, and we will now be happy to take your questions. Please limit your questions to a maximum of two so others can participate. Operator, please start the Q&A session.

Operator

Thank you. We will now begin the question and answer session. To ask a question, please press star followed by the number one on your phone and record your name clearly when prompted. To cancel your request, you may also press star followed by the number two. Our first question is from Tony Jones. Tony, your line is now open.

Tony Jones
Analyst, Redburn

Morning, everybody. Firstly, could you talk a little bit about price trends for 2018? Perhaps

Add in some detail in terms of how the negotiations with major customers are changing so you can do better than in last year. A question just on the EBIT bridge, slide 16. The other box. Please could you split that up into the various buckets? How much cost was there from inflation, restructuring expenses, and also help us understand what that cost control component was. Thank you.

Thierry Vanlancker
CEO, Akzo Nobel

Okay, well, thanks for the question. This is Thierry Vanlancker. I'll take the first half of the question, Maarten, maybe you focus on the EBIT bridge and those kinds of questions. On pricing, I think it's fair to say that Akzo Nobel has a track record of getting its own product prices aligned to the raw materials, we see no reason why that would not be the case going forward. In fact, we've seen in the fourth quarter, our prices going up, a lot of the announcements were done in the fourth quarter and in the first quarter. We're pretty, I think, optimistic on how we're going to correct that. Of course, if you ask the question for paints and coatings in general, because I think that's the segment that you're referring towards. It's a whole mixed bag on how those contracts are happening.

Going from store sales, which is almost instantaneous, to negotiations with bigger customers, where you often have a direct impact or quarterly impact, or half year or even a yearly impact, hence the fact that January 1 was an important date for many of those. In general, I would say that the price increases are of course, always a moment of tension with any customer, it's clear what the drivers are. We feel pretty encouraged by the progress we make. As we pointed out in previous calls during 2017, the biggest item was that it came somewhat unexpected for the whole industry during the first quarter. Comparisons with the first quarter also in 2018 will be more challenging because those were still the golden quarter versus then the hard work we had to do afterwards.

In addition to that, it came unexpected and it actually came rolling in continuously. Even the price increases that were done were actually then too little, in fact, very quickly as the raw materials kept edging upwards. Before I hand it over to Maarten, maybe one indication on what we expect as we get our own prices up with respect to raw materials. We do still expect increases in raw materials in 2018, somewhere in the single digits. We have taken that into account in our pricing actions in the market. We applied some intensity on how we get our prices up. We expect that not to alleviate in the coming months. Maarten, maybe on the EBIT.

Maarten de Vries
CFO, Akzo Nobel

On the EBIT bridge, you're talking about EUR 189 million other buckets. There is a net bucket indeed, that includes wage inflation. The wage inflation for paints and coatings is a little bit less than EUR 100 million. The gross number is you need to add that number, and then the saving buckets are basically across the board. It sits in G&A, sits in our selling expenses as well as our RD&I. As well as, I think that's also an important bucket to mention, partly is also stock revaluation, where the raw material prices are increasing. It's of course, also a positive effect in our stock revaluation coming in. That amount is, of course, also a material amount as part of this bucket.

Tony Jones
Analyst, Redburn

Thank you.

Operator

Next question is from Peter Clark. Your line's now open.

Peter Clark
Analyst, Societe Generale

Good morning. Thank you. I've got two questions. On the face of it, the paints and coatings margin, the hit year-on-year obviously seems to be alleviating. I do remember, of course, in Q4 2016, you were taking some charges in that number, particularly, I think, cost cutting in Marine and Protective and in the Performance Coatings. Just wondering if you could share what the number was in Q4 2016 of one-offs, because I don't think you had any restructuring in Q4 2017. Then also in terms of the Marine and Protective, which obviously remains quite challenging. Your competitors keep saying that as well. Obviously the lead time on new ship orders feeding through to coatings 15-18 months. I'm just wondering, given the work you're doing, obviously some alleviation potentially on raw materials as we go through 2018.

Did you expect this business to start reporting positive profit growth in the second half? Or do you think it will remain challenging on the profit reported for the full year? At Forex aside, of course. Thank you.

Thierry Vanlancker
CEO, Akzo Nobel

Let me maybe address the second part of your question and then go to the one-off question that you had. On Marine and Protective, Marine has its special dynamics and Protective has its special dynamics. It's all kind of linked to oil and gas. What we see if you ask around Marine, we do see the shipbuilding finally stabilizing and actually trending slightly upwards, but I wouldn't oversell that too much. I would say fortunately or maybe unfortunately, the timeline for recovery that we had indicated earlier in 2017 is still holding. We said end of 2018, beginning of 2019, that we see some trend upwards, because new build is more than half of that segment. We've done pretty strict cost control. That's ongoing also in Protective Coatings.

We put the two businesses also together because that allows To businesses, a growth model was not the right approach for the time being. I think your questions are also around then what other steps do we take, but as you know, we are the big player in that whole Marine and Protective space. Besides cost control and also raw materials, a lot of our ALPS contains improvements around efficiencies in raw materials that we do. We've also done the acquisition, for example, the Flexcrete acquisition is smack in the middle of our Protective business. It's a new technology that gets us into other parts than oil and gas for our Protective business. Two pretty exciting new developments.

We have a Chartek product that really can now efficiently, economically compete with the cementitious products, which is, in fact, the big player in there, and that was always a part of the market that was definitely to get into. What we've announced is LED technology for ship coatings, which is very sustainable, but actually a breakthrough in that market. It's a combination of cost, it's a combination of being efficient with your raw material, it's a combination also of continuing to look at different segments, and innovations to grow the market. I think we're well-positioned there, as we will explain also this afternoon. We have other markets that are growing very fast. These markets are finally stabilizing, and I think what we're focusing on is preparing the upturn, which we see more at the end of 2018, early 2019.

I hope that addresses your first question before I hand it over to Maarten for the one-off item.

Maarten de Vries
CFO, Akzo Nobel

On your question on the one-offs, where I have basically looked at is the Q4 2016 one-offs versus the Q4 2017 one-offs. In the total analysis of those one-offs, basically, these are equal. There is not one-offs going to the EBIT line, which is impacting the EBIT in Q4 2017 versus 2016. On your specific question on the restructuring in Q4 2016, I don't know the exact details, and I would like to maybe take that offline, and then maybe we can follow up through the IR team.

Thierry Vanlancker
CEO, Akzo Nobel

Yeah.

Peter Clark
Analyst, Societe Generale

Okay. Thank you.

Operator

Next, we have Stefano Toffano. Your line is now open.

Stefano Toffano
Analyst, ODDO BHF Corporate & Markets

Yes, thank you. I have two small questions if I can. The first one is with regard to your other line. This morning, you provided us with a split between the continued element in coatings and the discontinued element of Specialty Chem. Going forward, can we assume that that is a reasonable assumption in terms of the split of what we should expect in that other line? The second point is regards to the comment that you made earlier with regards to the pension. On slide 22, we see that the continued operations are now in a surplus with regards to deficit, but you made the comment earlier that the coatings business cash top-ups will be linked to the actuarial deficit. Can you give us some kind of steer or expectation in terms of what the cash outflows would be in the standalone coatings business post the separation?

Thank you.

Maarten de Vries
CFO, Akzo Nobel

First, your question on the other line, that's a correct assumption, although, maybe let me make a specific remark on BA other for Paints and Coatings. Q4 was relatively low. As you see, the full year Paints and Coatings was EUR 115 million, and Q4 was EUR 13 million. Going forward, I would more assume an overall BA other line, which sits somewhere in between what it was in 2016 and 2017. For reference, 2016 was, I believe, EUR 188 million, and 2017 is EUR 115 million. As we have completely split it and the BA other line in Specialty Chemicals gives the right reference as well. On your pension question, yes, we have a surplus from an accounting point of view for Paints and Coatings, however, still an actuarial deficit. That means that we still continue to see top-up payments.

By the way, the triennial agreement will come up again mid this year. That is a point of further negotiation. We also will, as part of the separation, as part of the proceeds of the separation of Specialty Chemicals, we will look how we can further de-risk the pension funds going forward.

Stefano Toffano
Analyst, ODDO BHF Corporate & Markets

Okay. Thank you very much.

Operator

Next question is from Geoff Haire. Your line's now open.

Geoff Haire
Analyst, UBS

Good morning. Thank you for the opportunity to ask some questions. First of all, just on the 2020 targets that you've reaffirmed today, can you give us some idea of what assumptions you're making for Forex and raw materials relative to where they are today to basically reaffirm those targets? Then can you help us with understanding what the book value is for Specialty Chemicals so we can sort of work out what the tax base might be? Thank you.

Thierry Vanlancker
CEO, Akzo Nobel

All right. Maybe, I'll let Maarten handle the tax questions. That's a luxury I have with having him here around.

Maarten de Vries
CFO, Akzo Nobel

To the first questions, which are the assumptions for 2020. I think for the raw materials, and we will elaborate on that also this afternoon. For the reconfirming of the 15% by 2020, we will walk you through four value drivers, which each have three very specific projects, and in total it is 12 projects to get to 15% by 2020. To answer your question maybe in a more general way, we have not assumed any windfalls in raw materials, although I think that goes in waves, so that is probably an upside in it. What we've assumed is that what is the raw materials, what is the typical timing in the markets for getting our product pricing up, which has been historical, and we see that with a couple of quarters delay, we basically can offset those costs.

Thierry Vanlancker
CEO, Akzo Nobel

Those are the similar assumptions, which I think are reasonable assumptions in our plan. That is for the raw materials. For FX, those are more difficult. One are the translation ones in there. I think the underlying one is about the FX situation we have today. That may be completely spot on, that may be completely optimistic or completely pessimistic. We took basically today's situation as the implicit underlying assumption for that. For the other question around the tax, Maarten.

Maarten de Vries
CFO, Akzo Nobel

Yeah. For our Specialty Chemicals separation, we follow a dual track, either private sale or de-merger. Both scenarios have tax consequences, fair to say that the tax consequences for the private sale are higher versus the de-merger. In the overall picture and in the overall valuation, and the side-by-side analysis, we, of course, take that well into account to make sure that we have a proper, consistent analysis of both scenarios.

Geoff Haire
Analyst, UBS

Could you give us a number for the book value for Specialty Chemicals?

Maarten de Vries
CFO, Akzo Nobel

No, I'm not in a position to give that number.

Geoff Haire
Analyst, UBS

Okay. Thank you.

Operator

Next, we have Jeremy Redenius. Your line is now open.

Jeremy Redenius
Analyst, Sanford C. Bernstein

Hi, it's Jeremy Redenius from Bernstein. Thanks for taking the questions. First of all, on the 2020 guidance. At one point, when it was first announced, you were talking about exceeding market growth such that you had aspired to grow about 4% per annum to achieve that target. Just curious how your thinking around that has changed. I remember at one point you talked about maybe that'd include a little bit of bolt-on. With pricing perhaps at your back, how are you thinking about the growth towards that target as well? I'm especially curious how much operating leverage might help. Then secondly, coming back to that EBIT bridge on page 16. I'm trying to get some help to separate what might be ongoing versus one-off in nature in that. It sounds like wage inflation will obviously continue to be a headwind.

You've taken some cost control measures, if you could help us think through a little bit more about how sustainable those cost control measures would be. I can see hiring freezes and travel restrictions being something you can maintain for a little while, but tough to run for the long run. Clearly, the inventory revaluation wouldn't be ongoing. A little help about ongoing versus one-off there would be helpful. Thanks.

Thierry Vanlancker
CEO, Akzo Nobel

Jeremy, thank you. Let me answer the first question. By the way, I think the measures we took, most of them are sustainable. I think that's for Maarten, I think, to get into the detail. First, on your question around the underlying assumption for growth. You are right that in the previous conversations, I think also with you, I think we talked about deemphasizing the growth number and having that as a mix between organic and inorganic. We've done, of course, since we announced in April, much more detailed work, also looking at the shifts in raw material, et cetera, on the 15 by 20 plan, and we'll elaborate on that ad nauseam this afternoon. What we basically have built the plan on is not needing above-market growth. I just want to point out that we are at this 4% right now.

What was deemed as impossible at the beginning of the year, we have delivered that in a very difficult year. There was merit to it. We didn't think, and that was what I've been impressing, we didn't think it was prudent to build a plan on exuberant growth in the market because then it's all sorts of unintended circumstances can happen. We have built our plans on actually market growth assumptions, being at market, and delivering 15% return on sales under that assumption. Any upside in the details, let's say operational leverage, will help. We don't need that to get to the 15% by itself. I think we'll have more details this afternoon. Maarten, maybe you can talk around the EBIT.

Maarten de Vries
CFO, Akzo Nobel

How should you think of this going forward from an EBIT bridge point of view? We have basically a continuous improvement program running, and our continuous improvement program basically compensates wage inflation and cost inflation. You could take that as a kind of a net balancing act. On top of that, we will talk about it extensively this afternoon in the analyst roundtable. On top of that, we have a number of initiatives lined up to bring us to our 15% growth by 2020. Specifically, I want to say, we are on track to deliver that EUR 110 million cost savings, which we announced last year, and that will come through our bottom line in 2018.

Thierry Vanlancker
CEO, Akzo Nobel

Jeremy, maybe to add on that, if you look at the dynamics of 2017, I think the whole industry, including ourselves, had a certain exuberance in the first quarter. The raw materials came in, you have the typical inertia, which we then expressed a couple of quarters, I think that's what the whole industry is kind of referring to. To get our market prices back in line with raw materials. What we did is, to summarize, in the last four or five months of the year was what I would call good parenting. Is while we develop plans, as Maarten has explained, for ongoing structural savings and reset of the structures, et cetera, what we did is indeed do a number of items.

Some of them are more sustainable than others, I think that's what you do in good parenting of the business, while more sustainable elements kick in as we will be expressing this afternoon.

Jeremy Redenius
Analyst, Sanford C. Bernstein

I got it. Yeah.

Thierry Vanlancker
CEO, Akzo Nobel

I would say I'm actually very happy with our business and with our reaction. If I compare it to peers in our market, I think our paints and coatings business has shown billions.

Jeremy Redenius
Analyst, Sanford C. Bernstein

Okay. Understood. Okay. You basically had to ask the organization to tighten things up a bit, enable the bigger programs and the stronger programs to

Thierry Vanlancker
CEO, Akzo Nobel

Correct. Yeah.

Jeremy Redenius
Analyst, Sanford C. Bernstein

Okay. Understood. Okay, great. Thank you very much.

Operator

Thank you. Next question is from Alex Stewart. Your line is now open.

Alex Stewart
Analyst, Barclays

Hi there. Good morning. Just to go back to Stefano's question on the actuarial deficit. The ICI pension fund triennial review, I think, done at the beginning of this year, or at least some indication in the beginning of this year. Do you have any idea how that actuarial deficit has changed from the roughly EUR 1 billion that was last reported at the beginning of 2016? Thank you so much.

Maarten de Vries
CFO, Akzo Nobel

I didn't hear your question very well to be honest, your question is on the actuarial deficit and the change of the actuarial deficit. I mentioned earlier that we have kind of a triennial agreement in place that's coming up again, those discussions mid this year, and that will be, of course, a topic of discussion. Especially given the fact that from an IAS 19 perspective, we are in a surplus. Yeah, the discussion will get a different dynamic, but it's important to indicate that we still expect top-up payments going forward at this stage.

Alex Stewart
Analyst, Barclays

Okay, you don't have any sense for how that actuarial position for the ICI and the corporate funds have changed over the last 3 years?

Maarten de Vries
CFO, Akzo Nobel

No. Not at this stage.

Alex Stewart
Analyst, Barclays

Okay, thanks.

Operator

Next we have Mutlu Gundogan. Your line's now open.

Mutlu Gundogan
Analyst, ABN AMRO Bank

Yes, good morning. Clearly the first question is on raw materials. Just wondering what you're seeing on the supply side. Is that normalizing or now we are in spring. Any comments there would be helpful. Secondly, on your outlook, just wondering why you have not provided a quantitative outlook as you did last year.

Thierry Vanlancker
CEO, Akzo Nobel

Okay. There was one comment you made around availability, which I'm not sure you talked about, but let me talk a bit about the raw material situation. Availability was sometimes an issue in specific areas. I mean, that's definitely correct. I think our procurement organization has been able to mitigate that, so we didn't have any bigger items in there. Often comes then, if it's a tight market, that comes at a certain raw material cost, as we have discussed at length in previous answers for that. In that sense, I think we don't expect significant issues on getting the material. We do expect, as I've indicated, still increases in pricing for raw material, we estimate that to be in mid-single digit %. We have the plans in place to mitigate that. There's a number of elements that we have in place.

It also, in fact, is clear that we aim our pricing actions in our markets with that in mind, because we know that that actually is going to come. Let me just stop here because I didn't hear all of your question whether that answers the first part of your question.

Mutlu Gundogan
Analyst, ABN AMRO Bank

It does. It was a little bit specific on China, but it does, I think.

Thierry Vanlancker
CEO, Akzo Nobel

I mean, China, that's a whole different topic in itself. Yes, that had an impact in the TiO2 market, for example, notably, because there was a dislocation. In Asia, TiO2 prices really went significantly high. Second thing is that, of course, for our chemicals organization who has a big production stake in China, we had wins because some people were shut down. We had also had some losses because some people were shut down who were supplying you. It's kind of a mixed bag in general. On the second question, I think on the guidance, Maarten?

Maarten de Vries
CFO, Akzo Nobel

On the guidance, we've given clear guidance for 2020. As you know, we had a 15% return on sales and 25% return on investments. For 2018, we don't give specific guidance, but I think it's important to realize how 2017 shaped up and how that looks for 2018. Specifically 2017, the first quarter was a very strong quarter, in fact, the raw material prices started to kick in in the second quarter and from the second quarter onwards. That's also why we are flagging that we have a more challenging start of the year given challenging comps specifically for the first quarter, while we take time to make sure that price increases are coming through and basically supporting our margin going forward.

Thierry Vanlancker
CEO, Akzo Nobel

Yeah. Maybe to build on that, we haven't given a guidance, but I think we have earlier stated that in our 15% return on sales for 2020. That this is not a flat. There is going to be a big surprise in 2020. That we definitely want to have a curve that shows a logic from where we are right now to that number. That's also what we have in mind for-

Mutlu Gundogan
Analyst, ABN AMRO Bank

Okay, thank you.

Operator

Next question is from Charlie Webb. Your line is now open.

Charlie Webb
Analyst, Morgan Stanley

Morning, gentlemen. Just a few from my side. First off, just CapEx guidance for 2018. If you could give us any steer for the group as a whole and perhaps spitting out paints and coatings and Specialty Chemicals, that would be helpful. Second question, just on the negative mix. I understand, it's about the regions where you're growing faster, but perhaps you could dig into a little bit more detail in the regions, maybe Europe. You touched on the U.K., which regions are doing well, which regions are not doing so well, that is driving that significant negative mix in the fourth quarter. Should we expect that kind of mix effect to continue into 2018? Lastly, just on Specialty Chemicals, do you expect us to continue to see, I guess, positive price mix or price development into 2018?

Do you think, a large part of that was seen in 2017? That is all. Thank you very much.

Thierry Vanlancker
CEO, Akzo Nobel

Right. Let me answer your questions in reverse order and then end with Maarten handling the CapEx question. On Specialty Chemicals, yes, we do expect that to continue in 2018. That business, in fact, has a different dynamic in the sense that a lot of the raw material price throughs are pretty automatic. As raw materials still go up, that's what you will see. In addition to that business continues to do very strong in all segments and in all regions. We've announced about 14 capacity expansions last year in Specialty Chemicals. That's actually kind of a teaser for your CapEx question, and that continues to be the case, and all these projects were high and fast payback projects that we did.

Secondly, on the negative mix, we've indicated if I look at Decorative Paints, we see all our regions stabilizing or turning up, including Europe, Middle East, Africa, that was a bit down. In Europe, Middle East, Africa, the real growth tends to be outside of the traditional Europe, and therefore you see a price mix shift sometimes there too. What Asia is concerned, that is really going very strong for us. As we explained a couple of times, every time you look at Decorative Paints, you see a negative price mix, which is actually hiding very good efforts on price increases in the market. The Asian pricing levels are lower than they are in Europe. Having said that, the profitability, the return on sales for those businesses is actually very, very good. It's not that good at all.

It's just in the price mix column, it actually shows a negative. We expect that in large to continue as we see continued very strong in our Asia business. Just want to point out for Decorative Paints that despite having taken a big raw material blow in 2017, I mean, a fair share of the EUR 300 million, you will see that all in all that business has delivered about the same amount as what was a very strong 2016. Just putting it in perspective on how the Asia growth has played an effect in there. For the other segments, I think we see those that are growing and doing very well in our portfolio continue to do so. Looking at vehicle refinish, looking at Powder Coatings, and those businesses that actually were somewhat in regions that were somewhat challenged as marine protective we talked about.

I think that's going to continue. I don't see any major shift in price mix, but we'll see price increases coming in. With the CapEx, I think maybe, Maarten, you can handle that.

Maarten de Vries
CFO, Akzo Nobel

For CapEx, going forward, we'll be more or less in line with what you've seen in 2017. To be very specific, for paints and coatings will be around EUR 250 million, and for Specialty Chemicals will be around EUR 400 million.

Charlie Webb
Analyst, Morgan Stanley

Great. Thank you very much, guys.

Lloyd Midwinter
Director of Investor Relations, Akzo Nobel

Thank you everyone. I think that concludes our Q&A session and call for today. Thanks for your interest in Akzo Nobel. If you do have further questions or would like additional information, please contact investor relations. Full contact details available at akzonobel.com. Thank you.

Operator

That concludes today's conference. Thank you all for your participation. You may now disconnect.